496 related articles for article (PubMed ID: 25890005)
1. Custodiol-N, the novel cardioplegic solution reduces ischemia/reperfusion injury after cardiopulmonary bypass.
Veres G; Radovits T; Merkely B; Karck M; Szabó G
J Cardiothorac Surg; 2015 Feb; 10():27. PubMed ID: 25890005
[TBL] [Abstract][Full Text] [Related]
2. Vardenafil protects against myocardial and endothelial injuries after cardiopulmonary bypass.
Szabó G; Radovits T; Veres G; Krieger N; Loganathan S; Sandner P; Karck M
Eur J Cardiothorac Surg; 2009 Oct; 36(4):657-64. PubMed ID: 19523842
[TBL] [Abstract][Full Text] [Related]
3. Tetrahydrobiopterin improves cardiac and pulmonary function after cardiopulmonary bypass.
Szabó G; Seres L; Soós P; Gorenflo M; Merkely B; Horkay F; Karck M; Radovits T
Eur J Cardiothorac Surg; 2011 Sep; 40(3):695-700. PubMed ID: 21324707
[TBL] [Abstract][Full Text] [Related]
4. Pre-conditioning with the soluble guanylate cyclase activator Cinaciguat reduces ischaemia-reperfusion injury after cardiopulmonary bypass.
Radovits T; Korkmaz S; Miesel-Gröschel C; Seidel B; Stasch JP; Merkely B; Karck M; Szabó G
Eur J Cardiothorac Surg; 2011 Feb; 39(2):248-55. PubMed ID: 20591683
[TBL] [Abstract][Full Text] [Related]
5. Effects of Custodiol-N, a novel organ preservation solution, on ischemia/reperfusion injury.
Loganathan S; Radovits T; Hirschberg K; Korkmaz S; Koch A; Karck M; Szabó G
J Thorac Cardiovasc Surg; 2010 Apr; 139(4):1048-56. PubMed ID: 19945120
[TBL] [Abstract][Full Text] [Related]
6. Deferoxamine, the newly developed iron chelator LK-614 and N-alpha-acetyl-histidine in myocardial protection.
Koch A; Loganathan S; Radovits T; Sack FU; Karck M; Szabó GB
Interact Cardiovasc Thorac Surg; 2010 Feb; 10(2):181-4. PubMed ID: 19914924
[TBL] [Abstract][Full Text] [Related]
7. Effects of FP15, a peroxynitrite decomposition catalyst on cardiac and pulmonary function after cardiopulmonary bypass.
Radovits T; Beller CJ; Groves JT; Merkely B; Karck M; Szabó C; Szabó G
Eur J Cardiothorac Surg; 2012 Feb; 41(2):391-6. PubMed ID: 21733708
[TBL] [Abstract][Full Text] [Related]
8. Preclinical evaluation of coronary vascular function after cardioplegia with HTK and different antioxidant additives.
Schröder C; Heintz A; Pexa A; Rauen U; Deussen A
Eur J Cardiothorac Surg; 2007 May; 31(5):821-6. PubMed ID: 17321142
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of the non-adenosine analogue A1 adenosine receptor agonist (BR-4935) on cardiovascular function after cardiopulmonary bypass.
Veres G; Radovits T; Otila G; Hirschberg K; Haider H; Krieger N; Knoll A; Weigang E; Szabolcs Z; Karck M; Szabó G
Thorac Cardiovasc Surg; 2010 Mar; 58(2):86-92. PubMed ID: 20333570
[TBL] [Abstract][Full Text] [Related]
10. Impact of Custodiol-N cardioplegia on acute kidney injury after cardiopulmonary bypass.
Feirer N; Dieterlen MT; Klaeske K; Kiefer P; Oßmann S; Salameh A; Borger MA; Hoyer A
Clin Exp Pharmacol Physiol; 2020 Apr; 47(4):640-649. PubMed ID: 31869857
[TBL] [Abstract][Full Text] [Related]
11. New HTK-N46B cardioplegia provides superior protection during ischemia/reperfusion in failing hearts.
Trescher K; Hasun M; Baumgartner A; Dietl W; Wolfsberger M; Hallström S; Podesser BK
J Cardiovasc Surg (Torino); 2013 Jun; 54(3):413-21. PubMed ID: 23389583
[TBL] [Abstract][Full Text] [Related]
12. Response of the hypertrophied left ventricle to global ischemia. Comparison of hyperkalemic cardioplegic solution with and without verapamil.
Huddleston CB; Wareing TH; Boucek RJ; Hammon JW
J Thorac Cardiovasc Surg; 1992 May; 103(5):919-26. PubMed ID: 1533256
[TBL] [Abstract][Full Text] [Related]
13. The antioxidant N-acetylcysteine preserves myocardial function and diminishes oxidative stress after cardioplegic arrest.
Fischer UM; Cox CS; Allen SJ; Stewart RH; Mehlhorn U; Laine GA
J Thorac Cardiovasc Surg; 2003 Nov; 126(5):1483-8. PubMed ID: 14666023
[TBL] [Abstract][Full Text] [Related]
14. Role of poly(ADP-ribose) polymerase activation in the pathogenesis of cardiopulmonary dysfunction in a canine model of cardiopulmonary bypass.
Szabó G; Soós P; Bährle S; Zsengellér Z; Flechtenmacher C; Hagl S; Szabó C
Eur J Cardiothorac Surg; 2004 May; 25(5):825-32. PubMed ID: 15082289
[TBL] [Abstract][Full Text] [Related]
15. Effect of L-arginine cardioplegia on recovery of neonatal lamb hearts after 2 hours of cold ischemia.
Hiramatsu T; Forbess JM; Miura T; Mayer JE
Ann Thorac Surg; 1995 Nov; 60(5):1187-92. PubMed ID: 8526597
[TBL] [Abstract][Full Text] [Related]
16. The protective effect of puerarin against myocardial reperfusion injury. Study on cardiac function.
Fan LL; Sun LH; Li J; Yue XH; Yu HX; Wang SY
Chin Med J (Engl); 1992 Jan; 105(1):11-7. PubMed ID: 1576864
[TBL] [Abstract][Full Text] [Related]
17. Supplemental L-arginine during cardioplegic arrest and reperfusion avoids regional postischemic injury.
Sato H; Zhao ZQ; McGee DS; Williams MW; Hammon JW; Vinten-Johansen J
J Thorac Cardiovasc Surg; 1995 Aug; 110(2):302-14. PubMed ID: 7543634
[TBL] [Abstract][Full Text] [Related]
18. Custodiol-N™ cardioplegia lowers cerebral inflammation and activation of hypoxia-inducible factor-1α.
Hoyer A; Then Bergh F; Klaeske K; Lehmann S; Misfeld M; Borger M; Dieterlen MT
Interact Cardiovasc Thorac Surg; 2019 Jun; 28(6):884-892. PubMed ID: 30668864
[TBL] [Abstract][Full Text] [Related]
19. Anti-C5a monoclonal antibody reduces cardiopulmonary bypass and cardioplegia-induced coronary endothelial dysfunction.
Tofukuji M; Stahl GL; Agah A; Metais C; Simons M; Sellke FW
J Thorac Cardiovasc Surg; 1998 Dec; 116(6):1060-8. PubMed ID: 9832699
[TBL] [Abstract][Full Text] [Related]
20. Myocardial protection in donor heart preservation: a comparison between Bretschneider's histidine-tryptophan-ketoglutarate solution and cold blood cardioplegia.
Sung SY; Lin CY; Song JY; Tsai YT; Kao CH; Lee CY; Lin YC; Hsu PS; Tsai CS
Transplant Proc; 2014 May; 46(4):1077-81. PubMed ID: 24815133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
